FIRST-IN-HUMAN PHASE I/II CLINICAL TRIAL OF IG-TREGS FOR GVHD PREVENTION

被引：0

作者：

Lysandrou, Memnon ^{[1
]}

Kefala, Dionysia ^{[1
]}

Christofi, Panagiota ^{[1
,2
]}

Liga, Maria ^{[1
]}

Miggos, Antonis ^{[3
]}

Papagregoriou, Charys ^{[4
]}

Vlachonikola, Elisavet ^{[3
]}

Savvopoulos, Nikolaos ^{[1
]}

Zacharioudaki, Vassiliki ^{[1
]}

Vallianou, Ioanna ^{[2
]}

Sagiadinou, Eleutheria ^{[1
]}

Tsokanas, Dimitris ^{[1
]}

Theodorellou, Rodanthy ^{[5
]}

Papadopoulou, Anastasia ^{[2
]}

Triantafyllou, Evi ^{[1
]}

Sakellari, Ioanna ^{[2
]}

Costeas, Paul ^{[4
,6
]}

Chatzidimitriou, Anastasia ^{[3
]}

Yannaki, Evangelia ^{[2
]}

Spyridonidis, Alexandros ^{[1
]}

机构：

[1] Univ Patras, Univ Gen Hosp Patras, Patras, Greece

[2] George Papanikolaou Hosp, Thessaloniki, Greece

[3] Ctr Res & Technol Hellas, Inst Appl Biosci, Thessaloniki, Greece

[4] Ctr Study Hematol & Other Malignancies, Nicosia, Cyprus

[5] Pharmassist Ltd, Athens, Greece

[6] Karaiskakio Fdn, Nicosia, Cyprus

来源：

BONE MARROW TRANSPLANTATION | 2024年 / 59卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P568

引用

页码：534 / 535

页数：2

共 50 条

[41] First-in-human phase I clinical trial of a recombinant vesicular stomatitis virus (rVSV)-based preventive HIV-1 vaccine
Fuchs, J. D.
Frank, I.
Kochar, N.
Elizaga, M.
Allen, M.
Carter, D.
Frahm, N.
Kalams, S. A.
Mulligan, M.
Sheets, R.
Pensiero, M.
Clarke, D.
Eldridge, J.
RETROVIROLOGY, 2012, 9
[42] First-in-human VLP Peanut Vaccine Candidate: Safety and Tolerability Data from on-going Phase I/IIa Clinical Trial
Oriel, Roxanne
Shreffler, Wayne
Casale, Thomas
Santos, Alexandra
Vogelberg, Christian
Kim, Edwin
Shamji, Mohamed
Wilkie, David
Eser, Sema
Zuiani, Chiara
Starchenka, Sviatlana
Adura, Peter
Mcardle, Eamonn
Krebs, Marietta
Oppenlaender, Lena
Hewings, Simon
Sellwood, Fiona
Kramer, Matthias
Graessel, Anke
Skinner, Murray
de Kam, Pieter-Jan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB446 - AB446
[43] First-in-human clinical trial of genetically engineered B cells: Application to the treatment of mucopolysaccharidosis type I
McIvor, R. Scott
Hampe, Christiane S.
Grandea, Glen
Olson, Erik R.
Meeker, Kole D.
Papia, Cassidy
Solan, Joell
Hayes, Robert
Ainsworth, Sean
Orchard, Paul J.
Wesley, Jacob
Sikorski, Robert
MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
[44] Biological and Clinical Impact of JAK2/mTOR Blockade in Gvhd Prevention: Preclinical and Phase I Trial Results
Pidala, Joseph
Walton, Kelly
Elmariah, Hany
Kim, Jongphil
Mishra, Asmita
Bejanyan, Nelli
Nishihori, Taiga
Khimani, Farhad
Perez, Lia
Faramand, Rawan
Davila, Marco L.
Nieder, Michael
Lawrence, Nicholas
Lawrence, Harshani
Anasetti, Claudio
Sebti, Said
Betts, Brian C.
BLOOD, 2020, 136
[45] Results of the first phase I/II clinical vaccination trial with direct injection of mRNA
Weide, Benjamin
Carralot, Jean-Philippe
Reese, Anne
Scheel, Birgit
Eigentler, Thomas Kurt
Hoerr, Ingmar
Rammensee, Hans-Georg
Garbe, Claus
Pascolo, Steve
JOURNAL OF IMMUNOTHERAPY, 2008, 31 (02) : 180 - 188
[46] First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers
Komdeur, Fenne L.
Singh, Amrita
van de Wall, Stephanie
Meulenberg, Janneke J. M.
Boerma, Annemarie
Hoogeboom, Baukje Nynke
Paijens, Sterre T.
Oyarce, Cesar
de Bruyn, Marco
Schuuring, Ed
Regts, Joke
Marra, Ruben
Werner, Naomi
Sluis, Jessica
van der Zee, Ate G. J.
Wilschut, Jan C.
Allersma, Derk P.
van Zanten, Coba J.
Kosterink, Jos G. W.
Jorritsma-Smit, Annelies
Yigit, Refika
Nijman, Hans W.
Daemen, Toos
MOLECULAR THERAPY, 2021, 29 (02) : 611 - 625
[47] FIRST-IN-HUMAN PHASE I CLINICAL TRIAL USING 8R-70CAR T CELLS FOR NEWLY DIAGNOSED ADULT GLIOBLASTOMA
Ghiaseddin, Ashley
Tao, Haipeng
Deleyrolle, Phuong
Rahman, Maryam
Rinonos, Serendipity Zapanta
Kresak, Jesse
Massini, Tara
Hiemenz, John
Robinson, Christopher
Hsu, Jack
Lin, Tuo
Wynne, Kristine
King, Jennifer
Hodik, Marcia
Lybarger, John
Manso, Eugenio Simon
Wang, Anqi
Sekora, David
Mckibben, Kathryn
Dechkovskaia, Anjelika
Castillo, Paul
Ligon, John
Sayour, Elias
Deleyrolle, Loic
Mitchell, Duane
Huang, Jianping
NEURO-ONCOLOGY, 2024, 26
[48] An open-label, first-in-human, phase I trial of the safety and efficacy of daily PCLX-001.
Sangha, Randeep S.
Sehn, Laurie Helen
Kuruvilla, John
Weickert, Michael
Mackey, John Robert
Berthiaume, Luc G.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[49] The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms In Vitro and in a First-In-Human Phase I Clinical Trial
Schwenzer, Hagen
De Zan, Erica
Elshani, Mustafa
van Stiphout, Ruud
Kudsy, Mary
Morris, Josephine
Ferrari, Valentina
Um, In Hwa
Chettle, James
Kazmi, Farasat
Campo, Leticia
Easton, Alistair
Nijman, Sebastian
Serpi, Michaela
Symeonides, Stefan
Plummer, Ruth
Harrison, David J.
Bond, Gareth
Blagden, Sarah P.
CLINICAL CANCER RESEARCH, 2021, 27 (23) : 6500 - 6513
[50] A first-in-human phase I trial with antibody drug conjugate ADCT-701 in neuroendocrine tumors and carcinomas
Del Rivero, Jaydira
Glod, John
Magee, Tamika
Cooper, Kimberley
Rivero, Anna
Lanfranconi, Tea
Patel, Rashmika
Figg, W. Douglas
Pommier, Yves
Widemann, Brigitte C.
Roper, Nitin
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : TPS672 - TPS672

← 1 2 3 4 5 →